Discoidin domain receptor Tyrosine Kinase 2 is highly expressed in ovarian cancer tissues and has been shown to enhance the invasive ability of tumor cells (Zhao et al., 2011). This evidence concerns the gene DDR2 and ovarian carcinoma.